Data research
We collect data and statistics about the fertility treatment cycles performed each year in the UK. We use this data to improve patient care and support researchers to conduct scientific research, whilst ensuring very strong protection of patient, donor and offspring confidentiality. This page provides more information about the Register data and how to access it.
The HFEA has recently launched a data research newsletter. This aims to provide information about the UK national register of fertility treatments held by the HFEA, including details on our upcoming reports and our award-winning dashboard, as well as further information on how to access data from our national UK fertility register for research purposes via the Register Research Panel (RRP). Sign up here to the newsletter Data Research Update.
What is the HFEA Register?
The Human Fertilisation and Embryology Authority (HFEA) is required by the Human Fertilisation and Embryology Act 1990 (The 1990 Act) to ensure every licensed fertility clinic in the United Kingdom (UK) submits treatment information, in order to retain oversight of the fertility sector. The HFEA holds information on fertility treatments, patients, partners, donors and children born as a result of these treatments in the UK on a secure databased known as ‘The Register’, which is believed to be the longest running database of its kind in the world.
We have collected data on all IVF and donor insemination treatments performed in the UK since 1 August 1991. In recent years this has represented over 70,000 fertility treatments annually. Summary register information can be accessed through our publications and dashboard. We also publish anonymised cycle level data for research purposes and further data can be made available to researchers through application to our Register Research Panel.
Nearly 1.8 million IVF treatment cycles undertaken between 1991 and 2021
Between 1991 and 2021, more than 390,000 live births resulted from fertility treatments
Around 55,000 patients had IVF or DI treatment in 2021
What data do we collect on our Register?
Clinics complete information about patients and their treatment cycles using specific forms. The types of forms, the information that we have collected, and the methods of data collection have changed over the years, so some of the data we hold is not present across all years of the Register or to the same degree of quality.
Our Register holds information about the following:
- Registration includes a record for each person involved in the treatment. This also includes demographics of patients, their partners, and donors.
- Treatment cycle and early outcomes includes a record for each treatment cycle and provides information about the cycle, including what type of cycle it is.
- Types of treatment in the Register include:
- Donor Insemination (DI)
- In-Vitro Fertilisation (IVF)
- Intracytoplasmic sperm injection (ICSI)
- Frozen embryo transfer (FET)
- Egg freezing
- Egg donation
- Embryo storage
- Where relevant, data on egg collection, egg thaw, embryo creation and use, and thaw transfer are available (e.g. the number of eggs collected, the number of embryos transferred).
- Early outcomes of IVF and DI includes data on the number of foetal pulsations and gestational sacs identified during the ultrasound scan around seven weeks after the treatment cycle.
- Outcome (for IVF and DI) includes foetal outcome, number of babies born, sex, and birthweight.
- Movement in and out of eggs/embryos/donor sperm includes a record of each movement into or out of storage of a licensed clinic for eggs, embryos and donor sperm.
It is important to note that while data on cycles using donor sperm, eggs, and/or embryos is collected on the Register, we are unable to disclose this information to researchers due to the Human Fertilisation and Embryology (Disclosure of Information for Research Purposes) Regulations 2010 (2010 Regulations).
For a current list of all data fields collected on the Register please see our Data Dictionary. You can also find details about commonly requested data fields in our FAQ section below.
How does the HFEA collect the Register data?
The Register is a database, compiled by the HFEA from data submitted by licensed fertility clinics through an electronic submission system. Data is typically available two years following the initial treatment, this is due to requirements on submitting outcome information from the clinics and the time required to complete data validation exercises.
How is consent collected?
Since the 2010 Regulations came into effect on 1 October 2009, patients have been given a consent form to choose whether they agree to allow personal information about themselves, and any child(ren) born as a result of the treatment, to be disclosed for research purposes. Patients can choose the personal information about the child(ren) to be handled differently.
The 2010 Regulations provided retrospective changes prior to 2009 to allow the use of register data in research. Patients were informed that they could opt-out of having their data used in research if they received treatment prior to 1 October 2009.
The national data opt-out is a policy that allows individuals to opt out of their confidential patient information being used for research and planning purposes. It does not apply in situations where the participant has given explicit consent for use of their data. This includes where the HFEA asks for patient’s consent to use personal information held in the Register for research purposes. However, the policy may apply if researchers plan to link to third party datasets.
Find out more about how we manage patient’s information.
Find out more about our Privacy Policy.
What about patient confidentiality?
Research can only take place within the strict confines of the laws, which provides very strong protection of patient, donor, and offspring confidentiality. Researchers must ensure anyone who has access to personal data understands their responsibilities for confidentiality, data protection and information security and is left in no doubt about the consequences of misconduct. Researchers must also certify that their organisation has met information governance requirements.
Any disclosure, even inadvertent or indirect, of an individual’s information that’s contained on our Register is a criminal offence outlined in the 1990 Act.
How can I obtain Register data?
There are two levels of Register data that can be provided for research. The level of data depends on the identifiability of the information.
1. Anonymised data
For researchers using Register data only and not linking to other datasets, our publicly available anonymised Register may be appropriate. This data has been stripped of any direct identifiers of patients and any children born as a result of treatment, and uses techniques such as suppression, offsetting and aggregation. This ensures that the HFEA anonymised Register adheres to the Information Standards Board’s Anonymisation Standard for Publishing Health and Social Care Data. The residual risk of re-identification is negligible or very low. This anonymised dataset contains a large proportion of all the Register data going back to 1991 and allows professionals in the sector and the wider research community to make good use of the data we collect, while protecting patient privacy.
Due to legislative changes in 2009, researchers can have greater coverage of treatment cycles using the anonymised dataset than one including personal information. For example, data on donor and donor-involved treatments are only available in anonymised data.
The anonymised datasets which contain data on treatment cycles between 1991 and 2018 are available below. For further information, please see the Guide to the Anonymised Register.
Anonymised register data for 2017 - 2018
Anonymised register data for 2015 - 2016
Anonymised register data for 2010 - 2014
Anonymised register data for 2005 - 2009
Anonymised register data for 2000 - 2004
Anonymised register data for 1995 - 1999
Anonymised register data for 1991 - 1994
Please see publications using the anonymised Register data.
Summary data can be requested through Freedom of Information. We publish our responses to information requests under the Freedom of Information Act (2000). You can read through previous answers or find out how to submit a request.
2. De-personalised or personally identifiable data
Use of either de-personalised or personally identifiable data will require an approval of the project from the HFEA Register Research Panel (RRP) and a favourable opinion from a Health Research Authority (HRA) established or recognised Research Ethics Committee (see Sections 6 of the application form).
De-personalised or de-identified data is stripped of direct identifiers, and cannot be easily linked to a specific person, but contains some fields which could be used to indirectly identify an individual through combinations of information by the people handling the data (e.g. sex, month and year of birth, date of embryo transfers, geographies or other personal characteristics). The data will be released with controls in line with the ICO Anonymisation Code of Practice.
The data request may include direct identifiers (e.g. name, NHS number, date of birth) and would be directly identifiable in the hands of the data recipient (such as by hospital number or a cohort-specific identifier). This may be necessary if a research project involves linking the Register dataset with other datasets, such as NHS health records. To access identifiable data, an existing legal gateway must be presented (see Section 5 of the application form).
The datasets created by the HFEA are usually cycle-based but can be individual-based which include records of patients with multiple cycles.
As indicated in “How is consent collected?”, personal information of patients and partners who did not provided their consents for disclosing data for research purpose will not be released.
Please see publications from the RRP approved projects below.
What is the Register Research Panel?
The Register Research Panel (RRP) is a committee run every two months by the HFEA. They make decisions on whether to grant or refuse applications from researchers to access de-personalised or personally identifiable data from the HFEA Register for research purposes.
All decisions made by the RRP are prescribed by the Human Fertilisation and Embryology (Disclosure of Information for Research Purposes) Regulations 2010 (2010 Regulations), which sets out when the HFEA may grant a request from a research establishment to process disclosable protected information. The RRP also receive annual updates about the approved research projects, to stay up-to-date on the ongoing research being carried out using Register data. Where changes are required to a research project, such as project extensions or a change in team members, researchers must submit requests for amendments to the RRP for approval.
How do I apply to the RRP?
If you are part of a UK-based research establishment (such as a university, other body or institution carrying out medical or other research), are interested in accessing de-personalised or personally identifiable data from the HFEA Register to use in your research, and you feel that your project is in the interests of the public and/or improving patient care and services, then you can contact us and start an application to the RRP.
- Contact us via RRP new research enquiry form to discuss your research project idea using HFEA Register data and the data you wish to have access to before you complete the application form. Not all enquiries need to progress to the formal application stage, for example it may be that your requirement can be satisfied through existing published data. Please include the following information in your enquiry:
- Your name
- Name of your research establishment
- A brief description of your project including research aims and objectives
- Data you are interested in
- Nature of the advice you are seeking
- Complete the RRP application form and data specification sheet. If you have any questions during the application process, please refer to the FAQ section below or email register.research@hfea.gov.uk.
On average it takes a minimum of 5 months to release data after a full approval at a RRP meeting. If further information is required or an application is conditionally approved additional 4 months likely to be added. Therefore, it is important to provide all the information necessary for the application with clear justification for the study and each of the data fields you wish to have access. - Send the following documents to register.research@hfea.gov.uk.
- A signed and completed RRP application form
- Data specification sheet
- A CV of the Chief Investigator
- Any other documents referred to in the completed application
- Your application will be processed, and we will confirm that we have received all required evidence to commence assessment of your application against the approval standards. We may request that you make some amendments or provide additional supplementary information before your application is ready to be considered by the RRP. Examples of this might include:
- Recommendations to add more details if the information provided is unclear
- Recommendations on changes to the data specification sheet, to ensure you will have the most valuable data to answer your research question
- A favourable opinion from a HRA established or recognised Research Ethics Committee (REC) is required to access de-personalised or personally identifiable data for a research project (see Section 6 of the application form). Once you have had confirmation from the HFEA team that the Register holds the data you are requesting, and that it would be available to access through the RRP, then you should submit a REC application through the HRA’s Integrated Research Application System (IRAS). It is not necessary to have received a favourable opinion from the REC by the time your project proposal is considered by the RRP, but an application to REC should have been submitted by the time of application to RRP.
- Completed applications will be added to the agenda of the next available RRP meeting, with the panel functioning on a first come first serve basis (at the time of final submission). The team will let you know the date of the meeting your project will be considered at. Unfortunately, it is not guaranteed that the application will be added to the closest calendar meeting as there is limited availability on each agenda, but the team will aim to do so wherever possible. The panel will make one of the following decisions:
- Approve the application
- Conditionally approve the application
- For example, in circumstances where you are awaiting an opinion from REC, the RRP may grant approval conditional on receiving a favourable opinion from REC, and no data will be released until those documents have been received.
Usually up to 56 days will be given to address the conditions.
- For example, in circumstances where you are awaiting an opinion from REC, the RRP may grant approval conditional on receiving a favourable opinion from REC, and no data will be released until those documents have been received.
- Seek further clarification
- The panel may require additional clarification on a few specific areas before they are able to make their final decision. As an example, this may be a request for additional justification on a specific data field, or it may be to confirm security arrangements.
- Where clarification is sought, you have 56 days to submit additional information before your application is automatically refused. Wherever possible we will support you in providing this information to allow your project to be considered again at the next RRP meeting.
- Reject the application
- The panel will lay out their concerns and give indications of where improvements should be made for you to submit a new application in the future.
- We aim to send a letter regarding the decision within 20 working days of the RRP meeting, however for more complex outcomes, such as detailed requests for clarification, this may take longer.
What happens after our project is approved by the RRP?
After you have received notice that your application has been approved by the RRP, the team will get in touch to discuss your data authorisation. This will form a legally-binding contract laying out exactly what data you will receive, and your obligations in line with our regulations.
Additionally, if you will be using one or more third parties to carry out data linkage, we will also use this time to create data sharing/processing agreements for all parties to sign.
Once these agreements have been signed, we will require payment of £5,000 prior to creating your bespoke dataset. After payment has been received, we will prepare and send you the encrypted dataset described in your data authorisation within 90 days.
While your research project is ongoing you should consider the following:
- You will be required to submit an annual report to update the RRP on the progress of your report.
- Any amendments to your research project, including but not limited to those listed below, will need to be considered and approved by the RRP. Please contact us and submit the Register Research Project Change Form for:
- Change in organisation or chief investigator
- New variables requested for an existing data set (may incur a fee)
- Change in research aims
- Change in collaborators (the staff members in the research team who have access to the Register data)
- More recent data requested (may incur a fee)
- Another amendment which is not specified above
When your research project comes to an end, and/or your data authorisation from the HFEA has expired, you are required to destroy all data, and provide proof of data destruction to the RRP.
If you wish to continue to access the data after the current authorisation period, please contact us and submit the Register Research Project Renewal Form and submit to register.research@hfea.gov.uk.
Ongoing research projects approved by RRP
- Predict IVF outcomes using advanced machine learning techniques
Chief investigator: Floriane Moy
Research establishment: Gaia Ltd. - The impact of duration of freezing of IVF embryos on pregnancy and perinatal outcomes – analysis of U.K. national data
Chief investigator: Edwin Amalraj Raja
Research establishment: University of Aberdeen - General Health Outcomes in Subfertile Men: a UK register-based cohort study
Chief investigator: Alastair Sutcliffe
Research establishment: University College London - Associations between Assisted Reproductive Technologies and Women's Mental Health: an investigation using clinical data linkage
Chief investigator: Lauren Carson and Robert Stewart
Research establishment: South London and Maudsley NHS Trust - Effects of Assisted Reproductive Technology (ART) on long-term Birth Weight trends: A National Cohort Study
Chief investigator: Stephen Roberts
Research establishment: University of Manchester - Environmental determinants of IVF treatment
Chief investigator: Tom Clemens
Research establishment: University of Edinburgh - Educational outcomes in children born after assisted reproductive technology: a population-based linkage study
Chief investigator: Alastair Sutcliffe
Research establishment: University College London - Prolonged effects of assisted reproductive technologies on health of women and their children: a record linkage study for England (PEARL)
Chief investigator: Claire Carson
Research establishment: University of Oxford - General health and hospital admissions in children born after ART: a population based linkage study
Chief investigator: Alastair Sutcliffe
Research establishment: University College London - Development and validation of prognostic models to predict pregnancy outcomes following in-vitro fertilization (IVF) treatment
Chief investigator: David J McLernon
Research establishment: University of Aberdeen
Completed research projects approved by RRP
- Perinatal outcomes of singletons born following in-vitro fertilisation: a comparison of different embryo transfer strategies using UK data
David J McLernon, University of Aberdeen - Live birth predication model over multiple IVF cycles
Ines de Santiago, University of Cambridge - Ethnic variation in fresh and frozen embryo transfer outcomes
Mariano Mascarenas, Leeds Teaching Hospitals NHS Trust - Cancer risk in children born after IVF/ICSI
Alastair Sutcliffe, University College London - Cancer risk and mortality in women after IVF
Alastair Sutcliffe, University College London - Effect of ethnicity on the success of assisted reproduction technologies
Walid Maalouf, University of Nottingham - EpiHealth Outcomes Project: The effect of maternal age, embryo cryopreservation and culture on perinatal outcomes and child health
Daniel Brison, Central Manchester University Hospitals NHS Foundation Trust
What research has been done using data from the HFEA Register?
We rely on researchers to let us know when they have published research using our datasets. If you have a publication to contribute to the bibliography below, please contact us at register.research@hfea.gov.uk.
Publications from the RRP approved projects
- Hua, X., Rivero-Arias, O., Quigley, M. A., Kurinczuk, J. J., & Carson, C. (2023). Long-term healthcare utilization and costs of babies born after assisted reproductive technologies (ART): a record linkage study with 10-years’ follow-up in England. Human Reproduction, 38(12), 2507–2515.
- Ratna, M. B., Bhattacharya, S., & McLernon, D. J. (2023). External validation of models for predicting cumulative live birth over multiple complete cycles of IVF treatment. Human Reproduction, 38(10), 1998–2010.
- Raja, E.A., Bhattacharya, S., Maheshwari, A., & McLernon, D. J. (2023). A comparison of perinatal outcomes following fresh blastocyst or cleavage stage embryo transfer in singletons and twins and between singleton siblings. Human Reproduction Open, 2023(2).
- Kondowe, F. J. M., Clayton, P., Gittins, M., D’Souza, S. W., Brison, D. R., & Roberts, S. A. (2023). Growth of twins conceived using assisted reproductive treatments up to 5 years old: a national growth cohort. Human Reproduction.
- McLernon, D. J., Raja, E. A., Toner, J. P., Baker, V. L., Doody, K. J., Seifer, D. B., Sparks, A. E., Wantman, E., Lin, P. C., Bhattacharya, S., & van Voorhis, B. J. (2022). Predicting personalized cumulative live birth following in vitro fertilization. Fertility and Sterility, 117(2).
- Raja, E. A., Bhattacharya, S., Maheshwari, A., & McLernon, D. J. (2022). Comparison of perinatal outcomes after frozen or fresh embryo transfer: separate analyses of singleton, twin, and sibling live births from a linked national in vitro fertilization registry. Fertility and Sterility, 118(2), 323–334.
- Ratna, M. B., Bhattacharya, S., van Geloven, N., & McLernon, D. J. (2022). Predicting cumulative live birth for couples beginning their second complete cycle of in vitro fertilization treatment. Human Reproduction, 37(9), 2075–2086.
- Sharpe, A., Mascarenhas, M., & Balen, A. (2022). Ethnic variation in the live birth rate and perinatal outcomes following frozen embryo transfer: an analysis of the HFEA database from 2000 to 2016. Human Fertility, 25(3), 583–592.
- Sutcliffe, A. G., Purkayastha, M., Brison, D. R., Nelson, S. M., Roberts, S. A., & Lawlor, D. A. (2022). General health in a cohort of children conceived after assisted reproductive technology in the United Kingdom: a population-based record-linkage study. American Journal of Obstetrics and Gynecology, 228(1).
- Bhattacharya, S., Maheshwari, A., Ratna, M. B., van Eekelen, R., Mol, B. W., & McLernon, D. J. (2021). Prioritising IVF treatment in the post COVID 19 era: a predictive modelling study based on UK national data. Human Reproduction, 36(3).
- Purkayastha, M., Roberts, S. A., Gardiner, J., Brison, D. R., Nelson, S. M., Lawlor, D., Luke, B., & Sutcliffe, A. (2021). Cohort profile: A national, population-based cohort of children born after assisted conception in the UK (1992-2009): Methodology and birthweight analysis. BMJ Open 11.
- Castillo, C. M., Harper, J., Roberts, S. A., O’Neill, H. C., Johnstone, E. D., & Brison, D. R. (2020). The impact of selected embryo culture conditions on ART treatment cycle outcomes: a UK national study. Human Reproduction Open, 2020(1).
- Cameron, N. J., Bhattacharya, S., & McLernon, D. J. (2020). Cumulative live birth rates following blastocyst- versus cleavage-stage embryo transfer in the first complete cycle of IVF: a population-based retrospective cohort study. Human Reproduction, 35(10), 2365–2374.
- van Eekelen, R., van Geloven, N., van Wely, M., Bhattacharya, S., van der Veen, F., Eijkemans, M. J., & McLernon, D. J. (2019). IVF for unexplained subfertility; whom should we treat? Human Reproduction, 34(7), 1249–1259.
- Hann, M., Roberts, S. A., D’Souza, S. W., Clayton, P., Macklon, N., & Brison, D. R. (2018). The growth of assisted reproductive treatment-conceived children from birth to 5 years: a national cohort study. BMC Medicine, 16(224).
- Williams, C. L., Bunch, K. J., Murphy, M. F. G., Stiller, C. A., Botting, B. J., Wallace, W. H., Davies, M. C., & Sutcliffe, A. G. (2018). Cancer risk in children born after donor ART. Human Reproduction, 33(1).
- Williams, C. L., Jones, M. E., Swerdlow, A. J., Botting, B. J., Davies, M. C., Jacobs, I., Bunch, K. J., Murphy, M. F. G., & Sutcliffe, A. G. (2018). Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation. BMJ (Online), 362.
- Cameron, N. J., Bhattacharya, S., Bhattacharya, S., & McLernon, D. J. (2017). Cumulative live birth rates following miscarriage in an initial complete cycle of IVF: a retrospective cohort study of 112 549 women. Human Reproduction, 32(11).
- Maalouf, W., Maalouf, W., Campbell, B., & Jayaprakasan, K. (2017). Effect of ethnicity on live birth rates after in vitro fertilisation/intracytoplasmic sperm injection treatment: analysis of UK national database. BJOG: An International Journal of Obstetrics and Gynaecology, 124(6).
- McLernon, D. J., Maheshwari, A., Lee, A. J., & Bhattacharya, S. (2016). Cumulative live birth rates after one or more complete cycles of IVF: a population-based study of linked cycle data from 178 898 women. Human Reproduction, 31(3).
- McLernon, D. J., Steyerberg, E. W., te Velde, E. R., Lee, A. J., & Bhattacharya, S. (2016). Predicting the chances of a live birth after one or more complete cycles of in vitro fertilisation: population based study of linked cycle data from 113 873 women. BMJ (Online), 355.
- Smith, A. D. A. C., Tilling, K., Nelson, S. M., & Lawlor, D. A. (2015). Live-birth rate associated with repeat in vitro fertilization treatment cycles. JAMA - Journal of the American Medical Association, 314(24).
- Lawlor, D. A., & Nelson, S. M. (2012). Effect of age on decisions about the numbers of embryos to transfer in assisted conception: A prospective study. The Lancet, 379(9815).
- Nelson, S. M., & Lawlor, D. A. (2011). Predicting live birth, preterm delivery, and low birth weight in infants born from in vitro fertilisation: A prospective study of 144,018 treatment cycles. PLoS Medicine, 8(1).
Projects using the anonymised Register
- Allen, C., McLernon, D., Bhattacharya, S., & Maheshwari, A. (2023). Early pregnancy outcomes of IVF cycles using donor versus partner sperm: analysis of 1 376 454 cycles recorded by the Human Fertilisation and Embryology Authority (1991–2016). Human Reproduction.
- Bambaranda, B. G. I. K., Bomiriya, R., Mehlawat, P., & Choudhary, M. (2022). Association of extended culture to blastocyst and pre-malignant gestational trophoblastic disease risk following IVF/ICSI-assisted reproduction cycles: an analysis of large UK national database. Journal of Assisted Reproduction and Genetics, 39(10).
- Shen, L., Zhang, Y., Chen, W., & Yin, X. (2022). The Application of Artificial Intelligence in Predicting Embryo Transfer Outcome of Recurrent Implantation Failure. Frontiers in Physiology, 13.
- Zhang, Y., Shen, L., Yin, X., & Chen, W. (2022). Live-Birth Prediction of Natural-Cycle In Vitro Fertilization Using 57,558 Linked Cycle Records: A Machine Learning Perspective. Frontiers in Endocrinology, 13.
- Lewin, J., Lukaszewski, T., Sangster, P., Williamson, E., McEleny, K., al Wattar, B. H., & Yasmin, E. (2022). Reproductive outcomes following surgical sperm retrieval in couples with male factor subfertility: A 10-year retrospective national cohort. Fertility and Sterility.
- Allen, C. P., McLernon, D. J., Bhattahcharya, S., & Maheshwari, A. (2022). Perinatal outcomes of 221,709 singleton and twin pregnancies after the use of donor versus partner sperm. Fertility and Sterility, 118(5), 948–958.
- Henderson, I., Lacey, L., Akhtar, M. A., & Quenby, S. (2022). Ethnic group and reason for ART failure: analysis of HFEA registry data from 2017-2018. Fertility and Sterility.
- Roberts, S. A., Wilkinson, J., Vail, A., & Brison, D. R. (2022). Does PGT-A improve assisted reproduction treatment success rates: what can the UK Register data tell us? Journal of Assisted Reproduction and Genetics.
- Mascarenhas, M., Mehlawat, H., Kirubakaran, R., Bhandari, H., & Choudhary, M. (2021). Live birth and perinatal outcomes using cryopreserved oocytes: an analysis of the Human Fertilisation and Embryology Authority database from 2000 to 2016 using three clinical models. Human Reproduction (Oxford, England), 36(5).
- Goyal, A., Kuchana, M., & Ayyagari, K. P. R. (2020). Machine learning predicts live-birth occurrence before in-vitro fertilization treatment. Scientific Reports, 10(1).
- Kamath, M. S., Antonisamy, B., & Sunkara, S. K. (2020). Zygotic splitting following embryo biopsy: a cohort study of 207 697 single-embryo transfers following IVF treatment. BJOG: An International Journal of Obstetrics and Gynaecology, 127(5).
- Supramaniam, P. R., Granne, I., Ohuma, E. O., Lim, L. N., McVeigh, E., Venkatakrishnan, R., Becker, C. M., & Mittal, M. (2020). ICSI does not improve reproductive outcomes in autologous ovarian response cycles with non-male factor subfertility. Human Reproduction, 35(3).
- Marconi, N., Raja, E. A., Bhattacharya, S., & Maheshwari, A. (2019). Perinatal outcomes in singleton live births after fresh blastocyst-stage embryo transfer: a retrospective analysis of 67 147 IVF/ICSI cycles. Human Reproduction, 34(9), 1716–1725.
- Supramaniam, P. R., Mittal, M., Ohuma, E. O., Lim, L. N., McVeigh, E., Granne, I., & Becker, C. M. (2019). Secondary sex ratio in assisted reproduction: an analysis of 1 376 454 treatment cycles performed in the UK. Human Reproduction Open, 2019(4).
- Henderson, I., Lacey, L., Akhtar, M. A., & Quenby, S. (2022). Ethnic group and reason for ART failure: analysis of HFEA registry data from 2017-2018. Fertility and Sterility.
- Sharpe, A., Avery, P., & Choudhary, M. (2018). Reproductive outcome following pre-implantation genetic diagnosis (PGD) in the UK. Human Fertility, 21(2).
- Kamath, M. S., Antonisamy, B., Mascarenhas, M., & Sunkara, S. K. (2017). High-risk of preterm birth and low birth weight after oocyte donation IVF: analysis of 133,785 live births. Reproductive BioMedicine Online, 35(3).
- Sunkara, S. K., Antonisamy, B., Selliah, H. Y., & Kamath, M. S. (2017a). Perinatal outcomes after gestational surrogacy versus autologous IVF: analysis of national data. Reproductive BioMedicine Online, 35(6).
- Sunkara, S. K., Antonisamy, B., Selliah, H. Y., & Kamath, M. S. (2017b). Pre-term birth and low birth weight following preimplantation genetic diagnosis: Analysis of 88 010 singleton live births following PGD and IVF cycles. Human Reproduction, 32(2).
- Ghuman, N. K., Mair, E., Pearce, K., & Choudhary, M. (2016). Does age of the sperm donor influence live birth outcome in assisted reproduction? Human Reproduction, 31(3).
- Maheshwari, A., Raja, E. A., & Bhattacharya, S. (2016). Obstetric and perinatal outcomes after either fresh or thawed frozen embryo transfer: an analysis of 112,432 singleton pregnancies recorded in the Human Fertilisation and Embryology Authority anonymized dataset. Fertility and Sterility, 106(7).
- Sunkara, S. K., Lamarca, A., Polyzos, N. P., Seed, P. T., & Khalaf, Y. (2016). Live birth and perinatal outcomes following stimulated and unstimulated IVF: Analysis of over two decades of a nationwide data. Human Reproduction, 31(10).
- Sunkara, S. K., Khalaf, Y., Maheshwari, A., Seed, P., & Coomarasamy, A. (2014). Association between response to ovarian stimulation and miscarriage following IVF: An analysis of 124 351 IVF pregnancies. Human Reproduction, 29(6).
- Maalouf, W. E., Mincheva, M. N., Campbell, B. K., & Hardy, I. C. W. (2014). Effects of assisted reproductive technologies on human sex ratio at birth. Fertility and Sterility, 101(5), 1321–1325.
- Sunkara, S. K., Rittenberg, V., Raine-Fenning, N., Bhattacharya, S., Zamora, J., & Coomarasamy, A. (2011). Association between the number of eggs and live birth in IVF treatment: An analysis of 400 135 treatment cycles. Human Reproduction, 26(7).
- Roberts, S. A., McGowan, L., Hirst, W. M., Brison, D. R., Vail, A., & Lieberman, B. A. (2010). Towards single embryo transfer? modelling clinical outcomes of potential treatment choices using multiple data sources: Predictive models and patient perspectives. Health Technology Assessment, 14(38).
Frequently Asked Questions
Data
Can I receive information on treatments using donor sperm, eggs or embryos, or treatments undertaken by single patients or patients in a same-sex relationship?
In accordance with the Human Fertilisation and Embryology (Disclosure of Information for Research Purposes) Regulations 2010, we are explicitly forbidden from releasing personally identifiable information which identifies or relates to a donor treatment. Single patients and patients in a same-sex relationship will necessarily require the use of donor sperm, eggs or embryos. As such, information on these cycles is only available in an anonymised format. We direct researchers to the anonymised register for such information and our reports, such as Family formations in fertility treatment 2018 and Trends in egg, sperm and embryo donation 2020.
Can I receive information on treatments undertaken by patients in a surrogacy arrangement?
In accordance with the Human Fertilisation and Embryology (Disclosure of Information for Research Purposes) Regulations 2010, we are explicitly forbidden from releasing information which identifies or relates to a donor treatment. In most surrogacy arrangements, egg and/or sperm donations will be used in the treatment. As such, we would suggest using the anonymised register for information on such treatments.
Does the HFEA hold information on artificial insemination?
We collect very limited information when the sperm is provided by a partner. This information is only used for billing purposes and is not held on our Register.
When the sperm is provided by a donor, we collect detailed information, but are unable to share it with researchers. In accordance with the Human Fertilisation and Embryology (Disclosure of Information for Research Purposes) Regulations 2010, we are explicitly forbidden from releasing information which identifies or relates to a donor treatment. As such, information on such cycles is only available in an anonymised format. We direct researchers to the anonymised register for this.
Does the HFEA hold information about egg/embryo culture techniques, embryoscope photos of embryos, and/or gradings of embryo quality?
The HFEA Register does not hold information about the techniques/media/equipment used when preparing each egg/embryo for the fertility treatment. The HFEA also does not hold copies of images taken through embryoscopes of developing embryos prior to embryo transfer. While some clinics may collect this detailed information, it is not submitted to the HFEA and so we cannot assist with projects relating to these topics.
The HFEA Register does not hold information on the quality grade assigned to each embryo by the embryologist carrying out the fertility treatment. The only information clinics submit regarding embryo quality is the stage of embryo development at embryo transfer.
Data access and RRP
Can I apply for de-personalised or personally identifiable data if I am from an overseas establishment or based outside UK?
Access to de-personalised or personally identifiable data cannot be authorised to overseas establishments, however it may be possible to access data overseas through a collaboration with a research establishment based in the UK. We have a publicly available anonymised dataset available that may be of help in your research if a UK collaboration is not possible.
What support can I get when applying to the RRP?
We will support you in the initial stages of applying to the RRP and can provide information on data relevant to your research question. Please email register.research@hfea.gov.uk to find out more.
Your application will be processed and we will confirm that we have received all required evidence to commence assessment of your application against the approval standards. We may request that you make some amendments or provide additional supplementary information before your application is ready to be considered by the RRP. It may be that a second review by the team, with a few extra recommendations, is needed prior to your application being considered by the RRP. The number of reviews undertaken by the team will not factor in the final decision reached by the RRP once your project does go to panel.
When do RRP panel meetings take place?
The RRP meets every two months.
When will the panel review my application?
A completed application form, along with additional documents, is required before an application can be added to the next available agenda. Unfortunately, it is not guaranteed that the application will be added to the closest calendar meeting as there is limited availability on each agenda and the panel functions on a first come first serve basis.
How will I know the outcome of the meeting?
A letter outlining the panel decision will be sent to you. We aim to send this within 20 working days of the RRP meeting.
How long can I use the data for?
In the application you will have to specify the length of the project. Authorisation of data use will be based on this timeline to a maximum of five years in the first instance. Should you wish to extend the authorisation, you will be required to submit a project amendment form which will be considered by the RRP.
How much does it cost?
In accordance with the Human Fertilisation and Embryology (Disclosure of Information for Research Purposes) Regulations 2010, a fee of £5,000 will be charged to cover the cost of extracting data from the Register and preparing the information for disclosure. There may also be additional charges to cover required legal costs.
What amendments to a project need RRP approval?
Amendments to a project that would require RRP approval may include:
- Change in organisation or Chief Investigator
- New variable(s) requested for held dataset (this may incur a fee)
- Change in research aims
- Change in collaborators
- More recent data requests (this may incur a fee)
If you are unsure of whether a change will require RRP approval, please contact the HFEA at register.research@hfea.gov.uk to discuss the changes.
If you wish to continue to access the data after the current authorisation period, please contact us and submit the Register Research Project Renewal Form and submit to register.research@hfea.gov.uk.
Can I appeal a decision made by the RRP?
Appeals against the decisions of the RRP will be considered by the RRP in accordance with Regulation 12 of the 2010 Regulations.
If you are dissatisfied with the decision made, please email register.research@hfea.gov.uk in the first instance. Many disagreements can be resolved by a clarification, or the provision of additional information, and it is anticipated that most complaints and appeals will be resolved by this informal stage.
A formal appeal against a decision taken by the Register Research Panel should be submitted to the Chair of the RRP who will pass it on to the relevant members of the Register Research Review Panel.
The target processing time for holding a meeting and making a decision on an appeal will be within 60 calendar days of receipt of a validated formal appeal.
The Register Research Review Group may decide to:
- uphold or overturn the decisions of the Register Research Panel
- authorise access to Register data for the purposes of medical or non-medical research, or
- deny, suspend, revoke, vary or impose conditions upon an existing authorisation to access Register data.
Review date: 1 November 2026